JP2002543155A - 抗プロゲスチン及びプロゲスチンを含有する避妊組成物 - Google Patents

抗プロゲスチン及びプロゲスチンを含有する避妊組成物

Info

Publication number
JP2002543155A
JP2002543155A JP2000615048A JP2000615048A JP2002543155A JP 2002543155 A JP2002543155 A JP 2002543155A JP 2000615048 A JP2000615048 A JP 2000615048A JP 2000615048 A JP2000615048 A JP 2000615048A JP 2002543155 A JP2002543155 A JP 2002543155A
Authority
JP
Japan
Prior art keywords
substituted
alkyl
dihydro
dimethyl
benzo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000615048A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002543155A5 (cg-RX-API-DMAC10.html
Inventor
グラツブ,ゲイリー・エス
ジ,リン
ジヨーンズ,トツド・ケイ
テグリー,クリストフアー・エム
ツアング,プエン
テレフエンコ,ユージーン・エイ
フエンサム,アンドリユー
ブローベル,ジエイ・イー
エドワーズ,ジエイムズ・ピー
フレツチヤー,ホレイス・エイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,350 external-priority patent/US6444668B1/en
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of JP2002543155A publication Critical patent/JP2002543155A/ja
Publication of JP2002543155A5 publication Critical patent/JP2002543155A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
JP2000615048A 1999-05-04 2000-05-01 抗プロゲスチン及びプロゲスチンを含有する避妊組成物 Withdrawn JP2002543155A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US30471299A 1999-05-04 1999-05-04
US09/304,712 2000-04-19
US09/552,350 US6444668B1 (en) 1999-05-04 2000-04-19 Combination regimens using progesterone receptor modulators
US09/552,350 2000-04-19
PCT/US2000/011643 WO2000066164A1 (en) 1999-05-04 2000-05-01 Contraceptive compositions containing antiprogestinic and progestinic

Publications (2)

Publication Number Publication Date
JP2002543155A true JP2002543155A (ja) 2002-12-17
JP2002543155A5 JP2002543155A5 (cg-RX-API-DMAC10.html) 2007-06-21

Family

ID=26974177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000615048A Withdrawn JP2002543155A (ja) 1999-05-04 2000-05-01 抗プロゲスチン及びプロゲスチンを含有する避妊組成物

Country Status (14)

Country Link
EP (1) EP1173210B1 (cg-RX-API-DMAC10.html)
JP (1) JP2002543155A (cg-RX-API-DMAC10.html)
CN (1) CN1179753C (cg-RX-API-DMAC10.html)
AT (1) ATE275973T1 (cg-RX-API-DMAC10.html)
AU (1) AU4682000A (cg-RX-API-DMAC10.html)
CA (1) CA2372773A1 (cg-RX-API-DMAC10.html)
DE (1) DE60013798T2 (cg-RX-API-DMAC10.html)
DK (1) DK1173210T3 (cg-RX-API-DMAC10.html)
ES (1) ES2226833T3 (cg-RX-API-DMAC10.html)
HK (1) HK1043736B (cg-RX-API-DMAC10.html)
MX (1) MXPA01011311A (cg-RX-API-DMAC10.html)
PT (1) PT1173210E (cg-RX-API-DMAC10.html)
SI (1) SI1173210T1 (cg-RX-API-DMAC10.html)
WO (1) WO2000066164A1 (cg-RX-API-DMAC10.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007534760A (ja) * 2004-04-27 2007-11-29 ワイス プロゲステロン受容体調節剤の精製
JP2009511512A (ja) * 2005-10-13 2009-03-19 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 機能不全子宮出血の経口治療のための単相医薬製品の製造方法
JP2011520799A (ja) * 2008-05-06 2011-07-21 ウニベルジテート デス ザールランデス ヒトアルドステロン合成酵素cyp11b2の阻害剤

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002076953A1 (en) 2001-03-21 2002-10-03 Warner-Lambert Company Llc New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
AR040783A1 (es) 2002-10-11 2005-04-20 Ligand Pharm Inc 5-(1',1'-cicloaquil/alquenil) metiliden-1,2 -dihidro-5-h-cromeno [3,4- f] quiinolinas como compuestos moduladores selectivos de receptores de progesterona
TW200410968A (en) 2002-10-11 2004-07-01 Ligand Pharm Inc 5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds
AR047398A1 (es) * 2003-11-24 2006-01-18 Wyeth Corp Acoplamiento cruzado carbono- carbono catalizado por metales de transicion sobre soportes solidos
WO2006023158A2 (en) 2004-07-14 2006-03-02 Ligand Pharmaceuticals, Inc. Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical compositions containing these compounds
WO2006010142A2 (en) 2004-07-14 2006-01-26 Ligand Pharmaceuticals, Inc. Mineralocorticoid receptor modulator compounds, processes for their preparation, and their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3733478A1 (de) * 1987-10-01 1989-04-13 Schering Ag Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
DE4330234A1 (de) * 1993-09-02 1995-03-09 Schering Ag Verwendung von Gestagenen und kompetitiven Progesteronantagonisten zur Herstellung von Arzneimitteln für die weibliche Fertilitätskontrolle sowie Mittel enthaltend ein Gestagen und einen kompetitiven Progesteronantagonisten
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption
WO1996015794A1 (en) * 1994-11-22 1996-05-30 Balance Pharmaceuticals, Inc. Compositions and methods for contraception and for treatment of benign gynecological disorders
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
ATE213947T1 (de) * 1996-06-25 2002-03-15 Akzo Nobel Nv Progestogen-anti-progestogen therapien

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007534760A (ja) * 2004-04-27 2007-11-29 ワイス プロゲステロン受容体調節剤の精製
US8309594B2 (en) 2004-04-27 2012-11-13 Wyeth Llc Purification of progesterone receptor modulators
US8609712B2 (en) 2004-04-27 2013-12-17 Wyeth Llc Purification of progesterone receptor modulators
JP2009511512A (ja) * 2005-10-13 2009-03-19 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 機能不全子宮出血の経口治療のための単相医薬製品の製造方法
JP2011520799A (ja) * 2008-05-06 2011-07-21 ウニベルジテート デス ザールランデス ヒトアルドステロン合成酵素cyp11b2の阻害剤

Also Published As

Publication number Publication date
CN1179753C (zh) 2004-12-15
AU4682000A (en) 2000-11-17
ES2226833T3 (es) 2005-04-01
DK1173210T3 (da) 2005-01-24
HK1043736B (en) 2005-04-01
WO2000066164A1 (en) 2000-11-09
MXPA01011311A (es) 2003-07-14
PT1173210E (pt) 2005-01-31
DE60013798T2 (de) 2005-09-29
HK1043736A1 (en) 2002-09-27
WO2000066164A8 (en) 2001-05-03
SI1173210T1 (en) 2005-02-28
ATE275973T1 (de) 2004-10-15
DE60013798D1 (de) 2004-10-21
EP1173210A1 (en) 2002-01-23
CA2372773A1 (en) 2000-11-09
CN1349415A (zh) 2002-05-15
EP1173210B1 (en) 2004-09-15

Similar Documents

Publication Publication Date Title
US6509334B1 (en) Cyclocarbamate derivatives as progesterone receptor modulators
US6444668B1 (en) Combination regimens using progesterone receptor modulators
US7569564B2 (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
JP5523430B2 (ja) プロゲステロン受容体モジュレーターとしてのシクロチオカルバメート誘導体
JP2002543156A (ja) キナゾリノンおよびベンゾキサジン誘導体含有避妊用組成物
EP1173210B1 (en) Contraceptive compositions containing antiprogestinic and progestinic
AU766428B2 (en) Cyclocarbamate derivatives as progesterone receptor modulators
JP2003524626A (ja) プロゲステロンレセプタモジュレーターとしてのキナゾリノンおよびベンゾキサジン誘導体

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070427

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070427

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20071127

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20071127